{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:48:30Z","timestamp":1788407310478,"version":"build-2803163510"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1097\/mjt.0b013e3181a2b1a6","type":"journal-article","created":{"date-parts":[[2010,3,24]],"date-time":"2010-03-24T04:15:25Z","timestamp":1269404125000},"page":"e110-e114","source":"Crossref","is-referenced-by-count":16,"title":["Statin Therapy and Aortic Stenosis: A Systematic Review of the Effects of Statin Therapy on Aortic Stenosis"],"prefix":"10.1097","volume":"17","author":[{"given":"Rohit Seth","family":"Loomba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210202","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0735-1097(96)00563-3","article-title":"Clincal factors associated with calcific aortic valve disease.","volume":"29","author":"Stewart","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"R2-14-20210202","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.jacc.2007.07.064","article-title":"Clinical factors but not C reactive protein, predict progression of calcific aortic valve disease.","volume":"50","author":"Novaro","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R3-14-20210202","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0735-1097(94)00406-G","article-title":"Progression of aortic stenosis in 394 patients: relation to changes in myocardial and mitral valve dysfunction.","volume":"25","author":"Brener","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"R4-14-20210202","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/clc.4960141210","article-title":"Development and progression of aortic valve stenosis: atherosclerosis risk factor-a causal relationship? A clinical morphologic study.","volume":"14","author":"Mohler","year":"1991","journal-title":"Clin Cardiol"},{"key":"R5-14-20210202","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/01.CIR.90.2.844","article-title":"Characterizatin of the early lesion of degenerative valvular aortic stenosis.","volume":"90","author":"Otto","year":"1994","journal-title":"Circulation"},{"key":"R6-14-20210202","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0022-5223(19)41751-0","article-title":"Scanning and light microscopy of human aortic leaflets in stressed and relaxed states.","volume":"67","author":"Clark","year":"1974","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R7-14-20210202","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0003-4975(10)60554-1","article-title":"Stress sharing between the sinus and leaflets of canine aortic valve.","volume":"20","author":"Thubrikar","year":"1986","journal-title":"Ann Thoracic Surg"},{"key":"R8-14-20210202","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0002-9149(93)90799-I","article-title":"Rapidity of progression of aortic stenosis in patients with congenital bicuspid aortic valves.","volume":"71","author":"Beppu","year":"1993","journal-title":"Am J Cardiol"},{"key":"R9-14-20210202","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/oxfordjournals.eurheartj.a060602","article-title":"Factors associated with calcific aortic valve degeneration in the elderly.","volume":"15","author":"Lindroos","year":"1994","journal-title":"Eur Heart J"},{"key":"R10-14-20210202","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/heart.88.4.348","article-title":"T lymphocyte infiltration in non-rheumatic aortic stenosis: a comparative descriptive study between tricuspid and bicuspid aortic valves.","volume":"88","author":"Wallby","year":"2002","journal-title":"Heart"},{"key":"R11-14-20210202","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.amjcard.2005.11.086","article-title":"Relations of inflammation and novel risk factors to valvular calcification.","volume":"97","author":"Fox","year":"2005","journal-title":"Am J Cardiol"},{"key":"R12-14-20210202","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0024-3205(00)00680-9","article-title":"Lipophilic HmgCoA reductase inhibitor has an anti-inflammatory effect.","volume":"67","author":"Inoue","year":"2000","journal-title":"Life Sci"},{"key":"R13-14-20210202","doi-asserted-by":"crossref","first-page":"31725","DOI":"10.1074\/jbc.272.50.31725","article-title":"Inhibition of HMG CoA reductase blocks hypoxia mediated down regulation of endothelial nitric oxide synthase.","volume":"272","author":"Laufs","year":"1997","journal-title":"J Biol Chem"},{"key":"R14-14-20210202","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/labinvest.3780115","article-title":"Inhibition of monocyte chemotactic protein-1 synthesis by statins.","volume":"80","author":"Romano","year":"2000","journal-title":"Lab Invest"},{"key":"R15-14-20210202","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0021-9150(99)00193-8","article-title":"Atorvastatin reduces NF-kappB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells.","volume":"147","author":"Ortego","year":"1999","journal-title":"Atherosclerosis"},{"key":"R16-14-20210202","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","article-title":"Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.","volume":"336","author":"Barnes","year":"1997","journal-title":"N Engl J Med"},{"key":"R17-14-20210202","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/01.ATV.16.4.523","article-title":"Apolipoproteins B, A, and E accumulate in the morphologically early lesion of degenerative valvular aortic stenosis.","volume":"16","author":"OBrien","year":"1996","journal-title":"Aterioscler Thromb Vasc Biol"},{"key":"R18-14-20210202","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1161\/01.CIR.103.11.1522","article-title":"3rd, Gannon F, Reynold C, et al. Bone formation and inflammation in cardiac valves.","volume":"103","author":"Mohler","year":"2001","journal-title":"Circulation"},{"key":"R19-14-20210202","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1161\/01.CIR.0000070591.21548.69","article-title":"Human aortic valve calcification is associated with an osteoblast phenotype.","volume":"107","author":"Rajamannan","year":"2003","journal-title":"Circulation"},{"key":"R20-14-20210202","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1172\/JCI117205","article-title":"TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cell to calcify.","volume":"93","author":"Watson","year":"1994","journal-title":"J Clinic Invest"},{"key":"R21-14-20210202","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/01.CIR.92.8.2163","article-title":"Osteopontin is expressed in human aortic valvular lesions.","volume":"92","author":"OBrien","year":"1995","journal-title":"Circulation"},{"key":"R22-14-20210202","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1582-4934.2001.tb00172.x","article-title":"Statins: mechanism of action and effects.","volume":"5","author":"Stancu","year":"2001","journal-title":"J Cell Mol Med"},{"key":"R23-14-20210202","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1161\/01.CIR.91.10.2528","article-title":"Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels.","volume":"91","author":"Jukema","year":"1995","journal-title":"Circulation"},{"key":"R24-14-20210202","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.","volume":"359","author":"Rossebo","year":"2008","journal-title":"N Engl J Med"},{"key":"R25-14-20210202","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMoa043876","article-title":"A randomized trial of intensive lipid lowering therapy in calcific aortic stenosis.","volume":"352","author":"Cowell","year":"2005","journal-title":"N Engl J Med"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MJT.0b013e3181a2b1a6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:13:23Z","timestamp":1786040003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045391-201007000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3181a2b1a6","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}